¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦2ȸ AACR-KCA Joint Workshop on Precision Medicine in Cancer ¹× Á¦25Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2022-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦2ȸ AACR-KCA Joint Workshop on Precision Medicine in Cancer ¹× Á¦25Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2022-11-11
±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : ¼­¿ï·Ôµ¥È£ÅÚ Å©¸®½ºÅ»º¼·ë ¿Ü 2°³·ë  
±³À°ÁÖÁ¦ : Á¦2ȸ AACR-KCA Joint Workshop on Precision Medicine in Cancer ¹× Á¦25Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486  
À̸ÞÀÏ : cancer2@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 11 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 350,000¿ø      
ºñ°í 1. »çÀüµî·Ï:1) ȸ¿ø 10¸¸¿ø, 2) ȸ¿ø(¾÷ü), ºñȸ¿ø 15¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 25¸¸¿ø, 4) Àü°øÀÇ/Çлý 5¸¸¿ø2. ÀϹݵî·Ï:1) ȸ¿ø 20¸¸¿ø, 2) ȸ¿ø(¾÷ü), ºñȸ¿ø 25¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 35¸¸¿ø, 4) Àü°øÀÇ/Çлý 10¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 Crystal 08:30~08:55 Updated results of a phase I trial of PSMA-targeting TGF¥â-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer  Naomi B. Hass(University of Pennsylvania Health System, USA) 
±³À°½Ã°£ 11-11 Crystal 08:55~09:20 A novel mechanism of targeting both LAG-3 and PD-L1 with a bispecific antibody  ¹ÚÀ±(KIST) 
±³À°½Ã°£ 11-11 Crystal 09:20~09:45 CAR T-cell based combination immunotherapy for solid tumors  Prasad S Adusumilli(Memorial Sloan Kettering Cancer Center, USA) 
±³À°½Ã°£ 11-11 Crystal 09:45~10:10 Regulation of T cell immunity in lymph node and tumor  ÇÏ»óÁØ(¿¬¼¼´ë) 
È޽Ġ11-11  10:10~10:30 È޽Ġ () 
±³À°½Ã°£ 11-11 Crystal 10:30~10:55 Vaccines targeting mutant KRAS neoantigens in combination with immune checkpoint blockade  Neeha Zaidi(The Johns Hopkins Hospital, USA) 
±³À°½Ã°£ 11-11 Crystal 10:55~11:20 Determinants of neoantigen validity in cancer immunotherapy  ±è±ÇÀÏ(°æÈñ´ë) 
±³À°½Ã°£ 11-11 Crystal 11:20~11:45 Identification and characterization tumor-reactive T cells in malignant tumors through TCR analysis  Bo Li(UT Southwestern Medical Center, USA) 
±³À°½Ã°£ 11-11 Crystal 11:45~12:10 Characterization of tumor antigen-specific T cells in blood and tumors  ½ÅÀÇö(KAIST) 
È޽Ġ11-11  12:10~12:20 È޽Ġ () 
±³À°½Ã°£ 11-11 Crystal 12:20~13:00 Take hope further with abemacicilb for HR+, HER2- Breast Cancer patients  ¹Ú°æÈ­(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-11 Emerald 12:20~13:00 Let 1L Esophageal cancer patients start a Whole New World with Pembrolizumab  ±èÀÎÈ£(°¡Å縯ÀÇ´ë) 
È޽Ġ11-11  13:00~13:20 È޽Ġ () 
±³À°½Ã°£ 11-11 Crystal 13:20~13:45 PROTAC drugs in oncology: Concepts and cases  ÀÌÈ­Áø(¾÷Å׶ó) 
±³À°½Ã°£ 11-11 Crystal 13:45~14:10 Novel radiopharmaceutical therapy  ¿ÀÁÖÇö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-11 Crystal 14:10~14:35 Cancer nanotheranostics  ÀÓÇüÁØ(¼­¿ï´ë) 
±³À°½Ã°£ 11-11 Crystal 14:35~15:00 New therapeutic approaches for the intractable tumors  ÀÌÁ¤¹Î(Çѵ¿´ë) 
±³À°½Ã°£ 11-11 Emerald 13:20~13:45 Auto-contouring and online adaptive radiotherapy or AI  ±èÁø¼º(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-11 Emerald 13:45~14:10 MRI-guided radiotherapy and adaptation  ±èÁØ¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-11 Emerald 14:10~14:35 Genomic biomarker of radiotherapy and response prediction  Àå¹ü¼·(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Emerald 14:35~15:00 Response prediction of radiotherapy with radiomics  ½ÅÀç½Â(»ï¼º¼­¿ïº´¿ø) 
È޽Ġ11-11  15:00~15:20 È޽Ġ () 
±³À°½Ã°£ 11-11 Crystal 15:20~15:45 Minimal residual disease in colorectal cancer  ÇѼ¼¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Crystal 15:45~16:10 Spatial transcriptomics based on scRNA-sequencing  ±èŹÎ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-11 Crystal 16:10~16:35 The telomere maintenance mechanism spectrum and its dynamics in gliomas  ¹Úö±â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Crystal 16:35~17:00 Precision medicine-based platform trial  ¹Ú¿¬Èñ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-11 Emerald 15:20~15:45 Complete cytoreductive surgery for resetting PARPi or PD-1i-resistant recurrent ovarian, fallopian tubal, peritoneal carcinoma  ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11-11 Emerald 15:45~16:10 Role of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis  ±èÁ¾ÇÑ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-11 Emerald 16:10~16:35 Conversion surgery in unresectable pancreatic cancers  ÀåÁø¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Emerald 16:35~17:00 Surgical treatment for retroperitoneal sarcoma  À̱³¿ø(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦2ȸ AACR-KCA Joint Workshop on Precision Medicine in Cancer ¹× Á¦25Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2022-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ¿µ»óÀÇÇÐȸ (¿Â¶óÀÎ) Àü°øÀÇ ¿¬¼ö±³À°(¿µ»óÀÇÇÐ Ç°Áú°ü¸® Á¦ 2ºÎ : 2022-11-11
´ÙÀ½±Û (¿Â¶óÀÎ) û¼Ò³â Á¤½Å°Ç°­ ÃÖ±ÙÀÇ À̽´ ´Ù½Ã Àбâ : 2022-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 39 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 49 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 40 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 35 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 35 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 20 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 24 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 43 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 39 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 31 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 26 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 30 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 28 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 27 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 49 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷